A detailed history of Manufacturers Life Insurance Company, The transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 149,996 shares of BPMC stock, worth $13.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
149,996
Previous 168,759 11.12%
Holding current value
$13.5 Million
Previous $18.2 Million 23.75%
% of portfolio
0.01%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$84.1 - $120.5 $1.58 Million - $2.26 Million
-18,763 Reduced 11.12%
149,996 $13.9 Million
Q2 2024

Aug 14, 2024

SELL
$85.18 - $108.78 $1.32 Million - $1.68 Million
-15,461 Reduced 8.39%
168,759 $18.2 Million
Q1 2024

May 14, 2024

BUY
$73.17 - $99.79 $3.53 Million - $4.81 Million
48,251 Added 35.49%
184,220 $17.5 Million
Q4 2023

Feb 13, 2024

BUY
$43.96 - $92.84 $208,634 - $440,618
4,746 Added 3.62%
135,969 $12.5 Million
Q3 2023

Nov 15, 2023

BUY
$46.9 - $66.0 $371,260 - $522,456
7,916 Added 6.42%
131,223 $6.59 Million
Q2 2023

Aug 11, 2023

BUY
$42.2 - $66.37 $1.26 Million - $1.98 Million
29,809 Added 31.88%
123,307 $7.79 Million
Q1 2023

May 15, 2023

BUY
$37.97 - $50.0 $673,018 - $886,250
17,725 Added 18.96%
111,223 $5 Million
Q4 2022

Aug 11, 2023

BUY
$41.06 - $66.48 $507,337 - $821,426
12,356 Added 15.23%
93,498 $4.1 Million
Q4 2022

Feb 13, 2023

BUY
$41.06 - $66.48 $507,337 - $821,426
12,356 Added 15.23%
93,498 $4.1 Million
Q3 2022

Aug 11, 2023

BUY
$49.93 - $77.7 $963,149 - $1.5 Million
19,290 Added 31.19%
81,142 $5.35 Million
Q3 2022

Nov 03, 2022

BUY
$49.93 - $77.7 $963,149 - $1.5 Million
19,290 Added 31.19%
81,142 $5.35 Million
Q2 2022

Aug 11, 2023

SELL
$45.23 - $70.15 $66,035 - $102,419
-1,460 Reduced 2.31%
61,852 $3.12 Million
Q2 2022

Aug 15, 2022

SELL
$45.23 - $70.15 $66,035 - $102,419
-1,460 Reduced 2.31%
61,852 $3.19 Million
Q1 2022

Aug 11, 2023

SELL
$54.1 - $110.08 $2.59 Million - $5.27 Million
-47,911 Reduced 43.08%
63,312 $4.04 Million
Q1 2022

May 20, 2022

BUY
$54.1 - $110.08 $1.83 Million - $3.72 Million
33,822 Added 114.69%
63,312 $4.09 Million
Q4 2021

Feb 16, 2022

SELL
$94.25 - $115.99 $29,688 - $36,536
-315 Reduced 1.06%
29,490 $3.2 Million
Q3 2021

Nov 12, 2021

SELL
$80.98 - $109.47 $236,704 - $319,980
-2,923 Reduced 8.93%
29,805 $3.06 Million
Q2 2021

Aug 12, 2021

BUY
$82.78 - $101.0 $147,596 - $180,083
1,783 Added 5.76%
32,728 $2.88 Million
Q1 2021

May 03, 2021

SELL
$90.71 - $108.28 $176,430 - $210,604
-1,945 Reduced 5.91%
30,945 $3.01 Million
Q4 2020

Feb 12, 2021

BUY
$92.08 - $124.48 $102,945 - $139,168
1,118 Added 3.52%
32,890 $3.69 Million
Q3 2020

Nov 09, 2020

SELL
$66.45 - $92.7 $23,257 - $32,445
-350 Reduced 1.09%
31,772 $2.95 Million
Q2 2020

Aug 10, 2020

SELL
$57.09 - $79.27 $64,283 - $89,258
-1,126 Reduced 3.39%
32,122 $2.46 Million
Q1 2020

May 15, 2020

BUY
$48.11 - $82.22 $193,546 - $330,771
4,023 Added 13.77%
33,248 $1.94 Million
Q4 2019

Feb 14, 2020

SELL
$66.73 - $82.59 $60,590 - $74,991
-908 Reduced 3.01%
29,225 $2.34 Million
Q3 2019

Nov 12, 2019

SELL
$72.9 - $101.41 $159,140 - $221,378
-2,183 Reduced 6.76%
30,133 $2.21 Million
Q2 2019

Aug 14, 2019

BUY
$73.54 - $97.8 $397,557 - $528,706
5,406 Added 20.09%
32,316 $3.05 Million
Q1 2019

May 13, 2019

BUY
$48.7 - $86.6 $73,634 - $130,939
1,512 Added 5.95%
26,910 $2.16 Million
Q4 2018

Feb 14, 2019

SELL
$45.57 - $74.26 $60,425 - $98,468
-1,326 Reduced 4.96%
25,398 $1.37 Million
Q3 2018

Nov 14, 2018

SELL
$58.91 - $78.32 $220,028 - $292,525
-3,735 Reduced 12.26%
26,724 $2.09 Million
Q2 2018

Aug 14, 2018

SELL
$60.96 - $101.18 $52,791 - $87,621
-866 Reduced 2.76%
30,459 $1.93 Million
Q1 2018

May 15, 2018

SELL
$73.28 - $102.95 $63,094 - $88,639
-861 Reduced 2.68%
31,325 $2.87 Million
Q4 2017

Feb 08, 2018

BUY
$62.91 - $88.32 $172,876 - $242,703
2,748 Added 9.33%
32,186 $2.43 Million
Q3 2017

Nov 14, 2017

BUY
$42.37 - $69.67 $1.25 Million - $2.05 Million
29,438
29,438 $2.05 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.38B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.